Related Experiment Videos

Suppressive effect of aspirin on chromosome aberration induced by mitomycin C in mice

M Niikawa1, T Nakamura, H Nagase

  • 1Ichinomiya Women's Junior College, Japan.

Insights

Aspirin suppressed mitomycin C (MMC)-induced chromosome damage in mice. This protective effect was strongest when aspirin was given 24 hours after MMC exposure, suggesting it targets MMC metabolites.

Area of Science:

  • Toxicology
  • Pharmacology
  • Genetics

Background:

  • Mitomycin C (MMC) is a chemotherapeutic agent known to induce chromosome aberrations.
  • Understanding protective agents against genotoxicity is crucial for mitigating side effects.

Purpose of the Study:

  • To investigate the potential suppressive effects of aspirin on mitomycin C-induced chromosome aberrations in a mouse model.
  • To determine the optimal timing and administration route for aspirin's protective action.

Main Methods:

  • A mouse micronucleus test was employed using peripheral blood and bone marrow cells.
  • Aspirin was administered via intraperitoneal injection or orally at varying doses and time points (0.5, 6, 24 hours) after MMC exposure.
  • Cellular damage was assessed 48 hours post-MMC administration.

Main Results:

  • Aspirin significantly suppressed MMC-induced chromosome aberrations in a dose-dependent manner.
  • The suppressive effect was most pronounced when aspirin was administered 24 hours after MMC.
  • Intraperitoneal aspirin injection at 24 hours reduced micronuclei frequency by 60-80%, while oral administration reduced it by 40-70%.

Conclusions:

  • Aspirin exhibits a protective effect against mitomycin C genotoxicity in mice.
  • The timing of aspirin administration is critical, with later administration showing greater efficacy.
  • Aspirin likely acts on mitomycin C metabolites rather than the parent compound.

Related Concept Videos